# Simvastatin (Zocor) Therapy in Sickle Cell Disease

> **NCT00508027** · PHASE1,PHASE2 · COMPLETED · sponsor: **UCSF Benioff Children's Hospital Oakland** · enrollment: 42 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT00508027
- **Lead sponsor:** UCSF Benioff Children's Hospital Oakland
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2013-09-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00508027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00508027, "Simvastatin (Zocor) Therapy in Sickle Cell Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00508027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*